More

    Finance

    Y-mAbs Therapeutics' SWOT analysis: antibody innovator's stock faces growth hurdles

    https://www.investing.com/news/swot-analysis/ymabs-therapeutics-swot-analysis-antibody-innovators-stock-faces-growth-hurdles-93CH-4061059 Investing.com

    New Germany fund sees $509,592 stock purchase by Saba Capital

    https://www.investing.com/news/insider-trading-news/new-germany-fund-sees-509592-stock-purchase-by-saba-capital-93CH-4061060 Investing.com

    Atossa Therapeutics CEO Steven Quay buys $9,886 in common stock

    https://www.investing.com/news/insider-trading-news/atossa-therapeutics-ceo-steven-quay-buys-9886-in-common-stock-93CH-4061061 Investing.com

    YouTube hires former Disney veteran to oversee sports and media

    https://www.investing.com/news/stock-market-news/youtube-hires-former-disney-veteran-to-oversee-sports-and-media-4061043 Reuters

    North Korea launches probe into accident during warship's launch

    https://www.investing.com/news/world-news/north-korea-launches-probe-into-accident-during-warships-launch-4061044 Reuters

    White House 'MAHA' report calls out food, chemicals impact on children's health

    https://www.investing.com/news/world-news/white-house-report-to-outline-causes-of-americas-declining-health-4059067 Reuters

    Ross Stores withdraws annual forecasts due to tariff pressures

    https://www.investing.com/news/stock-market-news/ross-stores-withdraws-annual-forecasts-due-to-tariff-pressures-4060693 Reuters

    Sunnova extends forbearance agreement amid debt pressure

    https://www.investing.com/news/sec-filings/sunnova-extends-forbearance-agreement-amid-debt-pressure-93CH-4061019 Investing.com

    Latest articles

    spot_imgspot_img